High materiality7/10
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital raises PTGX target to $178 from $112; current price $154.70.
- Target $178 (up from 112); price $154.70
Key facts
- 01
Target: $178
- 02
Posted price: $154.7
- 03
Analyst firm: BMO Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.